Literature DB >> 19065458

Tissue factor and its natural inhibitor in pre-eclampsia and SGA.

Offer Erez1, Roberto Romero, Debra Hoppensteadt, Nandor Gabor Than, Jawed Fareed, Shali Mazaki-Tovi, Jimmy Espinoza, Tinnakorn Chaiworapongsa, Sung-Su Kim, Bo Hyun Yoon, Sonia S Hassan, Francesca Gotsch, Lara Friel, Edi Vaisbuch, Juan Pedro Kusanovic.   

Abstract

OBJECTIVE: Tissue factor (TF), the major activator of the extrinsic pathway of coagulation, is abundant in the placenta and decidua. The aim of this study was to determine the maternal plasma concentrations of TF and its primary inhibitor, tissue factor pathway inhibitor (TFPI), in women who delivered small for gestational age (SGA) neonates, and in pre-eclampsia. STUDY
DESIGN: A cross-sectional study included the following groups: 1) women with normal pregnancies (n = 86); 2) patients who delivered SGA neonates (n = 61) and 3) women with pre-eclampsia (n = 133). Maternal plasma concentrations of TF and TFPI were measured by a sensitive immunoassay. Non-parametric statistics were used for analysis.
RESULTS: 1) Women with pre-eclampsia had a significantly higher median plasma concentration of TF than patients with a normal pregnancy (median: 1187 pg/mL; range: 69-11675 vs. median: 291.5 pg/mL; range: 6.3-2662.2; p < 0.0001, respectively); 2) Similarly, TFPI concentrations were higher in pre-eclampsia than in normal pregnancy (median: 87.5 ng/mL; range 25.4-165.1 vs. median: 66.1 ng/mL; range: 14.3-86.5; p < 0.0001, respectively); 3) Surprisingly, mothers with SGA neonates had a lower median maternal plasma concentration of TF (median: 112.2 pg/mL; range: 25.6-1225.3) than women with a normal pregnancy (p < 0.0001).
CONCLUSION: 1) Maternal plasma concentrations of TF in patients with pre-eclampsia, but not in those who delivered an SGA neonate, were higher than in women with normal pregnancies; 2) Although the role of immunoreactive plasma TF in coagulation remains controversial, our observations suggest that changes are present in the context of complications of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19065458      PMCID: PMC3171292          DOI: 10.1080/14767050802361872

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  197 in total

Review 1.  Angiogenesis and intrauterine growth restriction.

Authors:  A Ahmed; J Perkins
Journal:  Baillieres Best Pract Res Clin Obstet Gynaecol       Date:  2000-12

2.  Expression of tissue factor pathway inhibitor in human fetal and placental tissues.

Authors:  C S Edstrom; D A Calhoun; R D Christensen
Journal:  Early Hum Dev       Date:  2000-08       Impact factor: 2.079

3.  Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism.

Authors:  M Uszyński; E Zekanowska; W Uszyński; J Kuczyński
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-04       Impact factor: 2.435

Review 4.  Physiological function of tissue factor pathway inhibitor and interaction with heparins.

Authors:  P M Sandset; B Bendz; J B Hansen
Journal:  Haemostasis       Date:  2000

Review 5.  Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease.

Authors:  E Gratacós
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2000-09       Impact factor: 2.435

6.  Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.

Authors:  J B Hansen; B Svensson; R Olsen; M Ezban; B Osterud; R H Paulssen
Journal:  Thromb Haemost       Date:  2000-06       Impact factor: 5.249

7.  Risk factors for pre-eclampsia in an Asian population.

Authors:  C J Lee; T T Hsieh; T H Chiu; K C Chen; L M Lo; T H Hung
Journal:  Int J Gynaecol Obstet       Date:  2000-09       Impact factor: 3.561

8.  Neutrophil activation in preeclampsia and isolated intrauterine growth restriction.

Authors:  F Sabatier; F Bretelle; C D'ercole; L Boubli; J Sampol; F Dignat-George
Journal:  Am J Obstet Gynecol       Date:  2000-12       Impact factor: 8.661

9.  Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene.

Authors:  S Kamei; Y Kazama; J L Kuijper; D C Foster; W Kisiel
Journal:  Biochim Biophys Acta       Date:  2001-02-16

10.  Placental protein 5: disappearance from the circulation after delivery.

Authors:  B C Obiekwe; J Sooby; H T Salem; T Chard
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1982-02       Impact factor: 2.435

View more
  25 in total

1.  A molecular signature of an arrest of descent in human parturition.

Authors:  Pooja Mittal; Roberto Romero; Adi L Tarca; Sorin Draghici; Chia-Ling Nhan-Chang; Tinnakorn Chaiworapongsa; John Hotra; Ricardo Gomez; Juan Pedro Kusanovic; Deug-Chan Lee; Chong Jai Kim; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2011-02       Impact factor: 8.661

2.  High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Francesca Gotsch; Jawed Fareed; Debra Hoppensteadt; Nandor Gabor Than; Bo Hyun Yoon; Sam Edwin; Zhong Dong; Jimmy Espinoza; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-01

3.  Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at term.

Authors:  Pooja Mittal; Roberto Romero; Adi L Tarca; Juan Gonzalez; Sorin Draghici; Yi Xu; Zhong Dong; Chia-Ling Nhan-Chang; Tinnakorn Chaiworapongsa; Stephen Lye; Juan Pedro Kusanovic; Leonard Lipovich; Shali Mazaki-Tovi; Sonia S Hassan; Sam Mesiano; Chong Jai Kim
Journal:  J Perinat Med       Date:  2010-07-14       Impact factor: 1.901

4.  Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.

Authors:  Eleazar Soto; Roberto Romero; Juan Pedro Kusanovic; Giovanna Ogge; Youssef Hussein; Lami Yeo; Sonia S Hassan; Chong Jai Kim; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-25

5.  Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury.

Authors:  Patricia Redecha; Nico van Rooijen; Donald Torry; Guillermina Girardi
Journal:  Blood       Date:  2009-02-20       Impact factor: 22.113

6.  The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Samuel S Edwin; Chia-Ling Nhan-Chang; Nandor Gabor Than; Chong Jai Kim; Sun Kwon Kim; Lami Yeo; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-23

7.  Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Sam S Edwin; Yeon Mee Kim; Joon Seok Hong; Luis F Goncalves; Lami Yeo; Moshe Mazor; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07

8.  Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Authors:  Shali Mazaki-Tovi; Roberto Romero; Sun Kwon Kim; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Chia-Ling Nhan-Chang; Nandor Gabor Than; Ricardo Gomez; Jyh Kae Nien; Samuel S Edwin; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

9.  Maternal plasma soluble TRAIL is decreased in preeclampsia.

Authors:  Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Tamara Stampalija; Nandor Gabor Than; Zhong Dong; Jezid Miranda; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-13

10.  Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Josef M Cortez; Athina Pappas; Adi L Tarca; Piya Chaemsaithong; Zhong Dong; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.